A carregar...
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing
Chimeric antigen receptor (CAR)-expressing T cells are a promising therapeutic option for patients with cancer. We developed a new CAR directed against the disialoganglioside GD2, a surface molecule expressed in neuroblastoma and in other neuroectoderm-derived neoplasms. The anti-GD2 single-chain va...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4694800/ https://ncbi.nlm.nih.gov/pubmed/26298772 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|